LOUISVILLE, Colo., Oct. 9 /PRNewswire-FirstCall/ -- Replidyne, Inc. (Nasdaq: RDYN) announced today that it will host a conference call and webcast on Tuesday, October 30, 2007 at 4:45 P.M. EDT to report third quarter 2007 earnings. Callers may participate in the conference call by dialing 800-435-1261 (domestic) or 617-614-4076 (international), and providing the passcode 57078639.
A replay of the conference call will be available approximately one hour after completion of the call through Tuesday, November 13, 2007 at midnight. Callers may access the replay by dialing 888-286-8010 (U.S. participants) or 617-801-6888 (international participants). The audio replay passcode is 69926592. To access a replay of the webcast, visit the Investor Relations section of the company's website at http://www.Replidyne.com.
About Replidyne, Inc.
Replidyne is a biopharmaceutical company focused on discovering,
developing, in-licensing and commercializing innovative anti-infective
products. Replidyne's lead product, faropenem medoxomil, is a novel oral
community antibiotic, expected to be appropriate for use as a first-line
antibiotic for treatment of respiratory and skin infections in adult and
pediatric patients. Replidyne's second drug candidate, REP8839, is a
topical anti-infective product candidate in development for the treatment
of skin and wound infections, including methicillin-resistant S. aureus
(MRSA) infections. Replidyne's investigational antibacterial agent REP3123
targets Gram-positive C. difficile bacteria and C. difficile-associated
disease (CDAD). Replidyne is pursuing the development of other novel
anti-infective programs based on its in-house dis
|SOURCE Replidyne, Inc.|
Copyright©2007 PR Newswire.
All rights reserved